PMID- 35225227
OWN - NLM
STAT- MEDLINE
DCOM- 20220301
LR  - 20220405
IS  - 0392-856X (Print)
IS  - 0392-856X (Linking)
VI  - 40
IP  - 2
DP  - 2022 Feb
TI  - Measuring change in inclusion body myositis: clinical assessments versus imaging.
PG  - 404-413
LID - 10.55563/clinexprheumatol/0q2voe [doi]
AB  - Sporadic inclusion body myositis (sIBM) is a heterogeneous progressive 
      inflammatory muscle disease impacting skeletal muscles in the head, neck, and 
      limbs. Use of valid, reliable, sensitive, and standardised clinical and 
      paraclinical outcome assessments (COA) are critical to inform both proactive 
      clinical care and clinical trial design. Here we review clinical and imaging 
      methods used to quantify muscle strength, size, or function in sIBM, and discuss 
      their application to clinical practice and use in clinical trials. Considerations 
      for future work to validate measures in this population are also discussed.
FAU - Alfano, Lindsay N
AU  - Alfano LN
AD  - The Abigail Wexner Research Institute at Nationwide Children's Hospital, Center 
      for Gene Therapy, Columbus, and the Department of Paediatrics, The Ohio State 
      University College of Medicine, Columbus, OH, USA. 
      lindsay.alfano@nationwidechildrens.org.
FAU - Focht Garand, Kendrea L
AU  - Focht Garand KL
AD  - Department of Speech Pathology and Audiology, University of South Alabama, 
      Mobile, AL, USA.
FAU - Malandraki, Georgia A
AU  - Malandraki GA
AD  - Department of Speech, Language & Hearing Sciences, Purdue University, West 
      Lafayette, and Weldon School of Biomedical Engineering, Purdue University, West 
      Lafayette, IN, USA.
FAU - Salam, Sharfaraz
AU  - Salam S
AD  - Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, 
      University College London, UK.
FAU - Machado, Pedro M
AU  - Machado PM
AD  - Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, 
      University College London; Centre for Rheumatology, UCL Division of Medicine, 
      University College London; and NIHR University College London Hospitals 
      Biomedical Research Centre, London, UK.
FAU - Dimachkie, Mazen M
AU  - Dimachkie MM
AD  - Department of Neurology, The University of Kansas Medical Center, Kansas City, 
      KS, USA.
LA  - eng
PT  - Journal Article
PT  - Review
DEP - 20220207
PL  - Italy
TA  - Clin Exp Rheumatol
JT  - Clinical and experimental rheumatology
JID - 8308521
SB  - IM
MH  - Diagnostic Imaging
MH  - Humans
MH  - Muscle Strength
MH  - Muscle, Skeletal/diagnostic imaging
MH  - *Myositis, Inclusion Body/diagnostic imaging/therapy
EDAT- 2022/03/01 06:00
MHDA- 2022/03/03 06:00
CRDT- 2022/02/28 08:56
PHST- 2022/01/20 00:00 [received]
PHST- 2022/01/31 00:00 [accepted]
PHST- 2022/02/28 08:56 [entrez]
PHST- 2022/03/01 06:00 [pubmed]
PHST- 2022/03/03 06:00 [medline]
AID - 18325 [pii]
AID - 10.55563/clinexprheumatol/0q2voe [doi]
PST - ppublish
SO  - Clin Exp Rheumatol. 2022 Feb;40(2):404-413. doi: 
      10.55563/clinexprheumatol/0q2voe. Epub 2022 Feb 7.